Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds
Mourino V, Boccaccini AR (2010)
Publication Type: Journal article
Publication year: 2010
Journal
Publisher: Royal Society, The
Book Volume: 7
Pages Range: 209-227
Abstract
This paper provides an extensive overview of published studies on the development and applications of three-dimensional bone tissue engineering (TE) scaffolds with potential capability for the controlled delivery of therapeutic drugs. Typical drugs considered include gentamicin and other antibiotics generally used to combat osteomyelitis, as well as anti-inflammatory drugs and bisphosphonates, but delivery of growth factors is not covered in this review. In each case reviewed, special attention has been given to the technology used for controlling the release of the loaded drugs. The possibility of designing multifunctional three-dimensional bone TE scaffolds for the emerging field of bone TE therapeutics is discussed. A detailed summary of drugs included in three-dimensional scaffolds and the several approaches developed to combine bioceramics with various polymeric biomaterials in composites for drug-delivery systems is included. The main results presented in the literature are discussed and the remaining challenges in the field are summarized with suggestions for future research directions. © 2009 The Royal Society.
Authors with CRIS profile
Involved external institutions
United Kingdom (GB)How to cite
APA:
Mourino, V., & Boccaccini, A.R. (2010). Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. Journal of the Royal Society Interface, 7, 209-227. https://doi.org/10.1098/rsif.2009.0379
MLA:
Mourino, Viviana, and Aldo R. Boccaccini. "Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds." Journal of the Royal Society Interface 7 (2010): 209-227.
BibTeX: Download